AI could help accelerate drug discovery for age-associated diseases
At the recent NVIDIA Graphics Technology Conference (San Jose, CA, USA, 8–11 May 2017) AI scientists gave a presentation demonstrating the potential of AI deep learning-based approaches in drug discovery.
Please sign in or register for FREE to view this content
Sign in to MedChemNet
Register to MedChemNet – the medicinal chemistry network
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.